What is the recommended dose of adrenaline (epinephrine) infusion in a neonate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dose of Adrenaline (Epinephrine) Infusion in Neonates

For neonates requiring continuous epinephrine infusion after volume resuscitation, the recommended dose is 0.1-1.0 μg/kg per minute, starting at the lowest dose and titrating to the desired clinical effect. 1

Route of Administration and Dosing Guidelines

Intravenous (IV) Infusion

  • Initial dose: 0.1 μg/kg/min
  • Titration range: 0.1-1.0 μg/kg/min
  • Maximum dose: Up to 5 μg/kg/min may be necessary in severe cases 1
  • Concentration: Use 1:10,000 (0.1 mg/mL) solution for IV administration

Indications for Epinephrine Infusion

  • Continued shock after adequate volume resuscitation
  • Persistent hypotension unresponsive to fluid therapy
  • Cardiogenic shock or heart failure requiring inotropic support

Bolus Dosing (For Comparison)

While the question specifically asks about infusion dosing, it's important to understand how this differs from bolus dosing used in resuscitation:

  • IV bolus: 0.01-0.03 mg/kg (1:10,000 solution) 1, 2
  • Endotracheal bolus (if IV access unavailable): 0.05-0.1 mg/kg (1:10,000 solution) 1, 2
  • Repeat doses: Every 3-5 minutes if heart rate remains <60/min 1, 2

Administration Considerations

Safety Precautions

  • Monitor for extravasation, as IV infiltration can cause severe skin injury
  • If extravasation occurs, consider phentolamine (0.1-0.2 mg/kg up to 10 mg diluted in 10 mL of 0.9% sodium chloride) injected intradermally at the extravasation site 1
  • Use infusion pumps for precise delivery
  • Monitor vital signs continuously, especially blood pressure and heart rate

Potential Adverse Effects

  • Tachyarrhythmias and ectopic beats
  • Hypertension (especially with higher doses)
  • Peripheral, renal, and splanchnic vasoconstriction at higher doses
  • Decreased myocardial function with excessive doses 2

Evidence Quality and Recommendations

The recommendations for epinephrine infusion in neonates are based on very low-certainty evidence 1, 2. Most guidelines rely on extrapolation from adult and pediatric studies, animal models, and limited observational studies in neonates 3, 4.

The American Academy of Pediatrics and American Heart Association maintain these recommendations as the current standard of care despite the limited evidence base 2. Higher IV doses (>0.03 mg/kg for bolus or >1.0 μg/kg/min for infusion) are generally not recommended due to evidence of exaggerated hypertension, decreased myocardial function, and potential for worse neurological outcomes 2, 4.

Common Pitfalls to Avoid

  • Dosing errors are common when preparing epinephrine for neonatal use 5
  • Using adult concentrations (1:1,000) instead of the recommended neonatal concentration (1:10,000)
  • Failing to titrate based on clinical response
  • Delaying establishment of IV access when endotracheal administration is used
  • Not monitoring for extravasation, which can cause severe tissue damage
  • Administering high doses without adequate justification, which may worsen outcomes

Always verify the concentration and dose calculations before administration, particularly in emergency situations where errors are more likely to occur.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Neonatal Resuscitation Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

What is the optimal initial dose of epinephrine during neonatal resuscitation in the delivery room?

Journal of perinatology : official journal of the California Perinatal Association, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.